Holmes Biopharma, Inc. (LMB) Misses Q1 EPS by 65c, Slight Beat on Revenues; Boosts FY19 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/12/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Wall Street ends higher as investors turn to earnings season
Limbach Holdings Reports First Quarter 2018 Results
May 15, 2018 4:15 PM EDTQ1 2018 Revenues of $120.5 Million; Construction Revenues of $96.8 Million
Conference Call Scheduled for 9:00am ET Wednesday May 16, 2018
PITTSBURGH--(BUSINESS WIRE)-- Limbach Holdings, Inc. (NASDAQ: LMB) (Limbach or the Company) today announced financial results for the quarter ended March 31, 2018. Total revenues increased 4.7% versus the prior year period to $120.5 million in the first quarter of 2018. Construction segment revenue of $96.8 million grew 5.8% from the prior year period while Service segment revenues were flat at $23.7 million.
Other key financial highlights of the quarter included:
... More